001     875240
005     20220930130237.0
024 7 _ |a 10.1007/s00253-020-10643-7
|2 doi
024 7 _ |a 0171-1741
|2 ISSN
024 7 _ |a 0175-7598
|2 ISSN
024 7 _ |a 0340-2118
|2 ISSN
024 7 _ |a 1432-0614
|2 ISSN
024 7 _ |a 2128/25257
|2 Handle
024 7 _ |a altmetric:81748810
|2 altmetric
024 7 _ |a pmid:32385515
|2 pmid
024 7 _ |a WOS:000531119300001
|2 WOS
037 _ _ |a FZJ-2020-01889
082 _ _ |a 570
100 1 _ |a Milke, Lars
|0 P:(DE-Juel1)168455
|b 0
245 _ _ |a Engineering intracellular malonyl-CoA availability in microbial hosts and its impact on polyketide and fatty acid synthesis
260 _ _ |a New York
|c 2020
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1594217561_3683
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Biotechnologie 1
520 _ _ |a Malonyl-CoA is an important central metabolite serving as the basic building block for the microbial synthesis of many pharmaceutically interesting polyketides, but also fatty acid–derived compounds including biofuels. Especially Saccharomyces cerevisiae, Escherichia coli, and Corynebacterium glutamicum have been engineered towards microbial synthesis of such compounds in recent years. However, developed strains and processes often suffer from insufficient productivity. Usually, tightly regulated intracellular malonyl-CoA availability is regarded as the decisive bottleneck limiting overall product formation. Therefore, metabolic engineering towards improved malonyl-CoA availability is essential to design efficient microbial cell factories for the production of polyketides and fatty acid derivatives. This review article summarizes metabolic engineering strategies to improve intracellular malonyl-CoA formation in industrially relevant microorganisms and its impact on productivity and product range, with a focus on polyketides and other malonyl-CoA-dependent products.
536 _ _ |a 583 - Innovative Synergisms (POF3-583)
|0 G:(DE-HGF)POF3-583
|c POF3-583
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Marienhagen, Jan
|0 P:(DE-Juel1)144031
|b 1
|e Corresponding author
773 _ _ |a 10.1007/s00253-020-10643-7
|0 PERI:(DE-600)1464336-4
|p 6057–6065
|t Applied microbiology and biotechnology
|v 104
|y 2020
|x 0171-1741
856 4 _ |y OpenAccess
|z StatID:(DE-HGF)0510
|u https://juser.fz-juelich.de/record/875240/files/Malonyl-CoA%20Review%202020.pdf
856 4 _ |y OpenAccess
|x pdfa
|z StatID:(DE-HGF)0510
|u https://juser.fz-juelich.de/record/875240/files/Malonyl-CoA%20Review%202020.pdf?subformat=pdfa
856 4 _ |y Restricted
|z StatID:(DE-HGF)0599
|u https://juser.fz-juelich.de/record/875240/files/Milke-Marienhagen2020_Article_EngineeringIntracellularMalony.pdf
856 4 _ |y Restricted
|x pdfa
|z StatID:(DE-HGF)0599
|u https://juser.fz-juelich.de/record/875240/files/Milke-Marienhagen2020_Article_EngineeringIntracellularMalony.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:875240
|p openaire
|p open_access
|p OpenAPC_DEAL
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)168455
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)144031
913 1 _ |a DE-HGF
|b Key Technologies
|l Key Technologies for the Bioeconomy
|1 G:(DE-HGF)POF3-580
|0 G:(DE-HGF)POF3-583
|2 G:(DE-HGF)POF3-500
|v Innovative Synergisms
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b APPL MICROBIOL BIOT : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a APC
980 1 _ |a APC
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21